首页> 中文期刊> 《国际眼科杂志》 >睑板腺功能障碍临床诊断新进展

睑板腺功能障碍临床诊断新进展

         

摘要

睑板腺功能障碍(meibomian gland dysfunction,MGD)是眼科门诊常见的疾病之一,临床上MGD的诊断需根据症状、体征和相应的辅助检查进行综合评估.传统的检查方法如裂隙灯检查、泪膜破裂时间、泪液分泌试验等在MGD的诊断中有着明确的价值,而在2017年我国睑板腺功能障碍诊断与治疗专家共识中,一些新兴的临床检查方法如睑板腺缺失率、泪膜脂质层厚度等也作为MGD的辅助诊断标准.传统的方法和新兴的检测技术结合起来用于MGD的诊断,将会得到更全面、准确的结论.%· Meibomian gland dysfunction (MGD) is one of the common diseases in ophthalmology clinic.The diagnosis of MGD ought to be evaluated according to symptoms,signs and corresponding assistant examinations.Traditional examination methods,such as slit-lamp examination,break-up time of tear film,Schirmer tear test and so on,have definite value in the diagnosis of MGD.In 2017,the experts on the diagnosis and treatment of Meibomian gland dysfunction in our country have reached consensus that some novel clinical examination methods such as Meibomian gland loss rate and tear film lipid layer thickness are also worked as auxiliary diagnostic criteria for MGD.The combination of traditional methods and new detection techniques will lead to more comprehensive and accurate conclusions for the diagnosis of MGD.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号